Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.18.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.18.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.18.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.18.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.18.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.16.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.16.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.16.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.16.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.16.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.16.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LR.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LR.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LR.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
KR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
KR.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
KR.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
KR.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
KR.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
KR.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
KR.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.17.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.17.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.17.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.17.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.17.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.17.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.17.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.99.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.99.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.99.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used